GATTA, ANDREA

GATTA, ANDREA  

DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma 1-gen-2024 Reale, Alberto; Gatta, Andrea; Shaik, Amruth Kaleem Basha; Shallak, Mariam; Chiaravalli, Anna Maria; Cerati, Michele; Zaccaria, Martina; La Rosa, Stefano; Calistri, Arianna; Accolla, Roberto Sergio; Forlani, Greta
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 1-gen-2022 Gatta, A; Celesti, F; Chiaravalli, Am; Cerati, M; Shallak, M; Tedeschi, A; Sessa, F; Accolla, Rs; Forlani, G
Novel anti-glioblastoma therapeutic vaccines based on optimal stimulation of tumor specific CD4+ T helper cells 26-mar-2024 Gatta, Andrea
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma 1-gen-2024 Azzi, L.; Celesti, F.; Chiaravalli, A. M.; Shaik, A. K. B.; Shallak, M.; Gatta, A.; Battaglia, P.; La Rosa, S.; Tagliabue, A.; Accolla, R. S.; Forlani, G.
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA 1-gen-2023 Celesti, F.; Gatta, A.; Shallak, M.; Chiaravalli, A. M.; Cerati, M.; Sessa, F.; Accolla, R. S.; Forlani, G.
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy 1-gen-2023 Forlani, G.; Shallak, M.; Gatta, A.; Shaik, A. K. B.; Accolla, R. S.
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells 1-gen-2022 Celesti, F; Azzi, L; Shallak, M; Gatta, A; Accolla, Rs; Forlani, G